Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation - simplywall.st
20 hours ago • Google News
Nkarta Inc (NKTX)
US$ 2.05-4.65%
Price Chart
Key Statistics
Market Cap
$ 129.14M
P/E Ratio
0.00
Revenue (TTM)
$ 385
Volume
1.97M
52W High
$ 7.55
52W Low
$ 1.31
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
1.823
200-Day MA
2.3662
52 Week High
7.55
52 Week Low
1.31
About NKTX
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.
Employees
109
Headquarters
South San Francisco, CA
CEO
Mr. Paul J. Hastings
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg